Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Tamoxifen citrate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tamoxifen 20mg tablets
0803041S0AAABAB
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | 118,218 |
|
Tamoxifen 10mg tablets
0803041S0AAAAAA
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | 4,896 |
|
Tamoxifen 10mg/5ml oral solution sugar free
0803041S0AAAJAJ
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | 795 |
|
Tamoxifen 40mg tablets
0803041S0AAACAC
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | 80 |
|
Nolvadex D 20mg tablets
0803041S0BCABAB
|
Nolvadex | Tamoxifen citrate | Malignant Disease and Immunosuppression | 1 |
|
Emblon 10mg tablets
0803041S0BJABAA
|
Emblon | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Nolvadex 10mg tablets
0803041S0BCAAAA
|
Nolvadex | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Soltamox 10mg/5ml oral solution
0803041S0BLAAAJ
|
Soltamox | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamofen 10 tablets
0803041S0BFAAAA
|
Tamofen | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamofen 20 tablets
0803041S0BFABAB
|
Tamofen | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamofen 40 tablets
0803041S0BFACAC
|
Tamofen | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamoxifen 10mg/5ml oral liquid
0803041S0AAAHAH
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamoxifen 20mg/5ml oral liquid
0803041S0AAAGAG
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamoxifen 40mg/5ml oral liquid
0803041S0AAAIAI
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.